Display options
Share it on

Front Microbiol. 2012 Jun 21;3:222. doi: 10.3389/fmicb.2012.00222. eCollection 2012.

Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.

Frontiers in microbiology

Hiroo Hoshino

Affiliations

  1. Advanced Scientific Research-Leaders Development Unit, Gunma University Graduate School of Medicine Maebashi, Gunma, Japan.

PMID: 22737146 PMCID: PMC3380293 DOI: 10.3389/fmicb.2012.00222

Abstract

Human T cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T cell leukemia (ATL) and HTLV-1 - associated myelopathy and tropical spastic paraparesis (HAM/TSP). HTLV-1 has a preferential tropism for CD4 T cells in healthy carriers and ATL patients, while both CD4 and CD8 T cells serve as viral reservoirs in HAM/TSP patients. HTLV-1 has also been detected other cell types, including monocytes, endothelial cells, and dendritic cells. In contrast to the limited cell tropism of HTLV-1 in vivo, the HTLV receptor appears to be expressed in almost all human or animal cell lines. It remains to be examined whether this cell tropism is determined by host factors or by HTLV-1 heterogeneity. Unlike most retroviruses, cell-free virions of HTLV-1 are very poorly infectious. The lack of completely HTLV-1-resistant cells and the low infectivity of HTLV-1 have hampered research on the HTLV entry receptor. Entry of HTLV-1 into target cells is thought to involve interactions between the env (Env) glycoproteins, a surface glycoprotein (surface unit), and a transmembrane glycoprotein. Recent studies have shown that glucose transporter GLUT1, heparan sulfate proteoglycans (HSPGs), and neuropilin-1 (NRP-1) are the three proteins important for the entry of HTLV-1. Studies using adherent cell lines have shown that GLUT1 can function as a receptor for HTLV. HSPGs are required for efficient entry of HTLV-1 into primary CD4 T cells. NRP-1 is expressed in most established cell lines. Further studies have shown that these three molecules work together to promote HTLV-1 binding to cells and fusion of viral and cell membranes. The virus could first contact with HSPGs and then form complexes with NRP-1, followed by association with GLUT1. It remains to be determined whether these three molecules can explain HTLV-1 cell tropism. It also remains to be more definitively proven that these molecules are sufficient to permit HTLV-1 entry into completely HTLV-1-resistant cells.

Keywords: Env isomerization; Env proteins; cell tropism; epidemiology; glucose transporter GLUT1; heparan sulfate; neuropilin-1; syncytia formation

References

  1. Blood. 1990 Oct 15;76(8):1657-61 - PubMed
  2. J Virol. 1994 Oct;68(10):6323-31 - PubMed
  3. Virology. 2006 May 25;349(1):184-96 - PubMed
  4. J Immunol. 2005 Apr 1;174(7):4262-70 - PubMed
  5. Nat Med. 2008 Apr;14(4):429-36 - PubMed
  6. Int J Cancer. 1987 Sep 15;40(3):403-7 - PubMed
  7. J Virol. 2003 Sep;77(18):9922-30 - PubMed
  8. Blood. 2009 May 21;113(21):5176-85 - PubMed
  9. EMBO J. 2006 Jul 12;25(13):3045-55 - PubMed
  10. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7337-41 - PubMed
  11. Am J Trop Med Hyg. 1995 Oct;53(4):412-8 - PubMed
  12. J Exp Med. 1992 Jul 1;176(1):293-6 - PubMed
  13. AIDS Res Hum Retroviruses. 1996 Jul 1;12(10):941-50 - PubMed
  14. J Virol. 1996 Oct;70(10):7322-6 - PubMed
  15. Ann Neurol. 1995 Feb;37(2):167-75 - PubMed
  16. Blood. 2002 May 1;99(9):3335-41 - PubMed
  17. Lancet. 1986 May 3;1(8488):1031-2 - PubMed
  18. AIDS Res Hum Retroviruses. 1995 May;11(5):637-45 - PubMed
  19. Science. 1989 Apr 28;244(4903):471-5 - PubMed
  20. Int J Cancer. 1995 Feb 8;60(4):554-61 - PubMed
  21. J Clin Microbiol. 1992 Apr;30(4):905-10 - PubMed
  22. Blood. 2006 May 15;107(10):3976-82 - PubMed
  23. J Virol. 1992 Oct;66(10):5879-89 - PubMed
  24. Science. 2003 Mar 14;299(5613):1713-6 - PubMed
  25. J Virol. 2005 Apr;79(7):4533-9 - PubMed
  26. Eur J Haematol. 2008 Sep;81(3):209-17 - PubMed
  27. J Virol. 2003 Aug;77(15):8562-9 - PubMed
  28. J Virol. 1997 Oct;71(10):8073-7 - PubMed
  29. J Virol. 2008 Jul;82(14):7135-43 - PubMed
  30. J Virol. 2006 Sep;80(17):8291-302 - PubMed
  31. Cell. 1999 Oct 1;99(1):13-22 - PubMed
  32. J Biol Chem. 2005 Aug 12;280(32):29025-9 - PubMed
  33. Annu Rev Immunol. 1997;15:15-37 - PubMed
  34. Int Immunol. 2006 Feb;18(2):269-77 - PubMed
  35. J Immunol. 1991 Jul 1;147(1):354-60 - PubMed
  36. Virology. 2010 Jan 20;396(2):203-12 - PubMed
  37. Int J Cancer. 1984 Jun 15;33(6):745-9 - PubMed
  38. J Gen Virol. 1999 Jun;80 ( Pt 6):1429-1436 - PubMed
  39. Viruses. 2011 Jun;3(6):794-810 - PubMed
  40. Leuk Lymphoma. 1998 Feb;28(5-6):583-90 - PubMed
  41. Ann Neurol. 2004 Jul;56(1):10-9 - PubMed
  42. Virology. 2006 Sep 15;353(1):99-110 - PubMed
  43. Int J Cancer. 2007 May 1;120(9):2052-7 - PubMed
  44. Virology. 2000 Mar 1;268(1):41-8 - PubMed
  45. Blood. 2003 Apr 15;101(8):3085-92 - PubMed
  46. Retrovirology. 2010 Nov 29;7:99 - PubMed
  47. Adv Exp Med Biol. 2002;515:49-54 - PubMed
  48. Blood. 2001 Sep 15;98(6):1858-61 - PubMed
  49. J Virol. 2003 Mar;77(5):3281-90 - PubMed
  50. Infect Dis Clin North Am. 2000 Mar;14(1):211-39, x-xi - PubMed
  51. J Virol. 2004 Oct;78(19):10433-41 - PubMed
  52. Blood. 1987 Apr;69(4):1255-8 - PubMed
  53. J Virol. 2006 May;80(10):4771-80 - PubMed
  54. J Virol. 1994 Jun;68(6):3544-9 - PubMed
  55. EMBO J. 2004 Jan 14;23(1):54-65 - PubMed
  56. J Virol. 2008 May;82(10):4965-73 - PubMed
  57. Int J Cancer. 1982 Sep 15;30(3):257-64 - PubMed
  58. J Virol. 2001 Sep;75(18):8461-8 - PubMed
  59. J Immunol. 1992 Aug 1;149(3):940-8 - PubMed
  60. Jpn J Med. 1989 May-Jun;28(3):412-4 - PubMed
  61. J Infect Dis. 1991 Dec;164(6):1193-6 - PubMed
  62. Science. 1985 Aug 16;229(4714):675-9 - PubMed
  63. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7588-90 - PubMed
  64. Virology. 2006 Mar 1;346(1):194-204 - PubMed
  65. J Virol. 2005 Oct;79(20):12692-702 - PubMed
  66. Lancet. 1985 Aug 24;2(8452):407-10 - PubMed
  67. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4319-24 - PubMed
  68. Am J Pathol. 1998 Mar;152(3):683-9 - PubMed
  69. Blood. 2003 Mar 1;101(5):1913-8 - PubMed
  70. Cell. 2003 Nov 14;115(4):449-59 - PubMed
  71. Immunity. 2009 Oct 16;31(4):621-31 - PubMed
  72. J Virol. 2001 Sep;75(17):8317-28 - PubMed
  73. J Virol. 2001 Nov;75(21):10472-8 - PubMed
  74. Ann N Y Acad Sci. 1994 Jun 6;724:404-13 - PubMed
  75. J Infect Dis. 1990 Sep;162(3):649-54 - PubMed
  76. N Engl J Med. 1992 Feb 6;326(6):375-80 - PubMed
  77. Cancer Sci. 2011 Feb;102(2):295-301 - PubMed
  78. Cell. 2006 Feb 24;124(4):729-40 - PubMed
  79. J Virol. 2009 Nov;83(21):10908-21 - PubMed
  80. J Virol. 2012 Mar;86(6):2959-69 - PubMed
  81. Oncogene. 2005 Sep 5;24(39):6026-34 - PubMed
  82. J Virol. 2009 May;83(10):5244-55 - PubMed
  83. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S85-91 - PubMed
  84. Virology. 2000 Oct 25;276(2):455-65 - PubMed
  85. J Gen Virol. 2012 Mar;93(Pt 3):608-617 - PubMed
  86. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S132-45 - PubMed
  87. Oncogene. 2011 Mar 24;30(12):1379-89 - PubMed
  88. J Virol. 2002 Dec;76(24):12813-22 - PubMed
  89. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9 - PubMed
  90. Int J Cancer. 1987 Dec 15;40(6):755-7 - PubMed
  91. J Virol. 2000 Jul;74(14):6614-21 - PubMed
  92. Adv Exp Med Biol. 1993;329:545-9 - PubMed
  93. J Biol Chem. 2000 Aug 4;275(31):23417-20 - PubMed
  94. Int J Cancer. 2009 Nov 15;125(10):2375-82 - PubMed
  95. J Virol. 1997 Feb;71(2):1173-80 - PubMed
  96. J Immunol. 2008 Jan 15;180(2):931-9 - PubMed
  97. J Virol. 1998 Dec;72(12):9544-52 - PubMed
  98. AIDS Res Hum Retroviruses. 2005 Jan;21(1):43-50 - PubMed
  99. Oncogene. 2005 Sep 5;24(39):6058-68 - PubMed
  100. Int J Cancer. 1999 Sep 9;82(6):832-6 - PubMed
  101. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7591-5 - PubMed
  102. Blood. 2009 Jul 30;114(5):1016-25 - PubMed
  103. J Biol Chem. 2005 Aug 19;280(33):29653-60 - PubMed
  104. PLoS One. 2008 May 28;3(5):e2251 - PubMed
  105. J Emerg Med. 2000 Jan;18(1):109-19 - PubMed
  106. Oncogene. 2005 Sep 5;24(39):5996-6004 - PubMed
  107. J Cell Sci. 2004 Aug 1;117(Pt 17):3983-93 - PubMed
  108. AIDS Res Hum Retroviruses. 1992 Sep;8(9):1699-706 - PubMed
  109. J Virol. 2005 Sep;79(18):12088-94 - PubMed
  110. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6476-80 - PubMed
  111. Science. 1983 Dec 9;222(4628):1125-7 - PubMed
  112. Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20738-43 - PubMed
  113. Ann Intern Med. 1989 Oct 1;111(7):555-60 - PubMed
  114. J Virol. 2005 Apr;79(7):4150-8 - PubMed
  115. Nature. 1985 Dec 12-18;318(6046):571-4 - PubMed
  116. J Infect Dis. 1986 Nov;154(5):851-7 - PubMed
  117. Oncogene. 2005 Sep 5;24(39):6005-15 - PubMed
  118. Oncogene. 2005 Sep 5;24(39):6016-25 - PubMed
  119. Immunity. 2000 Nov;13(5):657-64 - PubMed
  120. AIDS Res Hum Retroviruses. 1994 Feb;10(2):163-73 - PubMed
  121. Int J Cancer. 1983 Sep 15;32(3):321-8 - PubMed
  122. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2110-4 - PubMed
  123. Proc Natl Acad Sci U S A. 1985 Apr;82(8):2277-81 - PubMed
  124. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3618-22 - PubMed
  125. Retrovirology. 2004 Dec 02;1:41 - PubMed
  126. Pathol Biol (Paris). 2009 Mar;57(2):161-6 - PubMed
  127. Virus Res. 1999 Apr;60(2):159-69 - PubMed
  128. J Virol. 2004 Apr;78(8):3837-45 - PubMed
  129. Nat Immunol. 2002 May;3(5):477-82 - PubMed
  130. Nat Med. 2010 Jan;16(1):83-9 - PubMed
  131. Virology. 1993 Sep;196(1):25-33 - PubMed
  132. J Immunol. 1993 Jul 15;151(2):1013-24 - PubMed
  133. Science. 1984 Sep 28;225(4669):1473-6 - PubMed
  134. Viruses. 2011 Jul;3(7):1131-65 - PubMed
  135. Leukemia. 1994 Apr;8 Suppl 1:S68-70 - PubMed
  136. PLoS Pathog. 2010 Feb 26;6(2):e1000788 - PubMed
  137. Lancet. 1992 Mar 14;339(8794):645-6 - PubMed
  138. Virology. 1984 Jul 30;136(2):338-47 - PubMed
  139. J Virol. 1990 Nov;64(11):5682-7 - PubMed
  140. J Virol. 2007 Jun;81(11):6019-31 - PubMed
  141. J Clin Invest. 1991 Oct;88(4):1315-22 - PubMed
  142. J Virol. 1992 Feb;66(2):906-13 - PubMed
  143. J Virol. 2000 Nov;74(21):9828-35 - PubMed
  144. Science. 1984 Jul 27;225(4660):381-5 - PubMed
  145. J Med Virol. 2002 Jul;67(3):427-30 - PubMed
  146. AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1711-5 - PubMed
  147. Biochem Biophys Res Commun. 1999 Aug 2;261(2):357-63 - PubMed
  148. Jpn J Cancer Res. 1985 Feb;76(2):86-94 - PubMed
  149. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8035-40 - PubMed
  150. J Biol Chem. 2009 Mar 6;284(10):6575-84 - PubMed
  151. Retrovirology. 2005 Mar 02;2:16 - PubMed
  152. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2031-5 - PubMed
  153. J Virol. 2006 Jul;80(14):6844-54 - PubMed
  154. J Virol. 1998 Dec;72(12):9955-65 - PubMed
  155. Cell. 1998 Mar 20;92(6):735-45 - PubMed
  156. Cell. 2000 Nov 10;103(4):679-89 - PubMed

Publication Types